Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Andrea V Margulis"'
Autor:
Andrea V Margulis, Sonia Hernandez-Diaz, Thomas McElrath, Kenneth J Rothman, Estel Plana, Catarina Almqvist, Brian M D'Onofrio, Anna Sara Oberg
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0214180 (2019)
BackgroundThe associations of individual antiepileptic drugs (AEDs) with pregnancy duration and size at birth, and potential dose relations, are not well characterized.MethodsThis cohort study used nationwide Swedish register data (1996-2013). Adjust
Externí odkaz:
https://doaj.org/article/a5485be332a04288b415469f8d02db2a
Autor:
Andrea V Margulis, Marie Linder, Alejandro Arana, Anton Pottegård, Ina Anveden Berglind, Christine L Bui, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Lisa J McQuay, Willem Jan Atsma, Kwame Appenteng, Milbhor D'Silva, Susana Perez-Gutthann, Jesper Hallas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204456 (2018)
PURPOSE:To describe the use of antimuscarinic drugs to treat overactive bladder (OAB) in Denmark, Sweden, and the United Kingdom (UK). METHODS:We identified new users of darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, and trospium ag
Externí odkaz:
https://doaj.org/article/5c7ff1827f6b40b49627f2619eafb006
Publikováno v:
Pharmacoepidemiology and Drug Safety.
We aimed to describe the distribution of gestational age at birth (GAB) to inform the estimation of GAB when clinical or obstetric estimates are not available for perinatal epidemiologic research. We estimated GAB (median, mode, mean, standard deviat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e37fd6ff9ad638c8c556db1425b21f5
https://doi.org/10.1101/2022.10.19.22281268
https://doi.org/10.1101/2022.10.19.22281268
Autor:
Pamela K. Foreman, Sarah Landis, Abenah Harding, Kimberly Alexander, Manel Pladevall-Vila, Andrea V. Margulis, Renée Shediac, Brian Calingaert
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-18 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
BackgroundPhenylalanine hydroxylase (PAH) deficiency is an autosomal recessive disorder that results in elevated concentrations of phenylalanine (Phe) in the blood. If left untreated, the accumulation of Phe can result in profound neurocognitive disa
Autor:
Andrea V. Margulis, Kwame Appenteng, Stefan de Vogel, Susana Perez-Gutthann, Lisa J. McQuay, Alejandro Arana, Cristina Varas-Lorenzo, Billy Franks, Maria Reynolds, Alicia Gilsenan, Christine L. Bui, Cristina Rebordosa
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could a
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 31(1)
PURPOSE Publications provide important information for clinicians, researchers, and patients. Key methodological elements must be reported for maximum transparency. We identified key methodological elements necessary for fully understanding perinatal
Autor:
Cheryl Enger, Libby Horter, Nina Sahlertz Kristiansen, Stefan de Vogel, Kelesitse Phiri, Brandon T. Suehs, Jesper Hallas, Alejandro Arana, Marie Linder, Ingvild Odsbu, Yihua Xu, Andrea V. Margulis, Kwame Appenteng, John D. Seeger, Morten Olesen, Veena Hoffman, Susana Perez-Gutthann
Publikováno v:
Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7
Drug Safety
Drug Safety
Introduction During clinical trials, mirabegron, a β3-adrenoreceptor agonist, was associated with increased vital signs vs placebo in patients with overactive bladder. Objective The purpose of this study was to compare incidence rates of adverse car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606ed98949016a3becf28423411ba054
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdf
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdf
Autor:
Alejandro Aranaa, Andrea V. Margulis
Publikováno v:
Epidemiology (Cambridge, Mass.). 32(5)
Publikováno v:
Current Epidemiology Reports. 6:380-389
We reviewed postauthorization pregnancy safety studies requested by regulatory agencies to explore which study approaches have been typically requested and to what extent these have changed over time. The most common study approach requested by the U